More from NUTRITION!
Retatrutide, a weekly shot that leans on three hormones at once, cut body weight by an average of 18.8% at its highest dose in adults with type 2 diabetes and obesity. That figure covers all 80 weeks of the trial… Read More →
NUTRITION
Diet and food.
-
-
A Drug Best Known for Psoriasis Put More Ulcerative Colitis Patients Into Remission
A drug that has spent years clearing psoriasis plaques just posted its numbers in a different fight. In two linked phase 3 trials, half of the people with moderate to severe ulcerative colitis who kept taking guselkumab every four weeks… Read More →
-
A Muscle-Sparing Drug Deepened Fat Loss When Added to Semaglutide
The muscle mostly stayed. That's the result that sets the BELIEVE trial apart from the usual weight-loss study. Among 507 adults with obesity, those given bimagrumab, an infusion designed to protect muscle, together with weekly semaglutide lost 17.8 kilograms, about… Read More →
-
Donor Stool Transplants Came Up Short in Irritable Bowel Syndrome
If you live with irritable bowel syndrome, you've probably run into the promise that fixing your gut bacteria could fix your gut. The most rigorous test of that idea has now reported, and the promise didn't hold. Among 450 Norwegian… Read More →
-
Daily Fish Oil Left Fracture Risk Unchanged in Older Adults
Fish oil didn't protect anyone's bones. That's the blunt summary of the largest randomized test yet of omega-3 fatty acids and fractures, which followed 25,871 US adults for a median of 5.3 years. People taking a daily gram of marine… Read More →
-
Orforglipron, a Daily GLP-1 Pill, Cut Weight in Adults With Diabetes
The GLP-1 drugs that reshaped weight loss have mostly come as weekly injections. A pill would change who can reach them. In a trial of 1,613 adults who had both obesity and type 2 diabetes, the once-daily tablet orforglipron cut… Read More →
-
A New Weekly Shot, Mazdutide, Cut Weight in Chinese Adults With Obesity
A weekly injection that leans on two of the body's hormone signals at once cut body weight by about 14% over 48 weeks in a randomized trial of 610 Chinese adults with obesity or weight-related health problems, while placebo left… Read More →
-
A Next-Generation Stool Test Caught More Colon Cancers Than the Standard Home Kit
If you've been putting off a colonoscopy, the alternative usually arrives as a small kit in the mail. Among 20,176 U.S. adults who tried both kinds of kit before a screening colonoscopy, a next-generation stool DNA test—marketed under the brand… Read More →
-
High-Dose Fish Oil Reached the Brain but Didn’t Sharpen Memory
The fish oil arrived exactly where it was supposed to go. It just didn't do anything once it got there. Across a two-year trial of 365 older adults at raised risk of dementia, high-dose DHA capsules sharply lifted omega-3 levels… Read More →
-
The First Approved Fatty Liver Medicine Improved Both Inflammation and Scarring
Until 2024, a common liver disease had no approved medicine at all. The tablet that ended that run, resmetirom, earned its approval by clearing the disease's hallmark inflammation in up to 29.9% of patients against 9.7% on placebo, and improving… Read More →